Axsome Therapeutics (AXSM) Misses Q4 EPS by 58c
Tweet
Share
E-mailGet Alerts AXSM Hot Sheet
Join SI Premium – FREE
Axsome Therapeutics (NASDAQ: AXSM) reported Q4 EPS of ($1.54), $0.58 worse than the analyst estimate of ($0.96). Revenue for the quarter came in at $117.32 million versus the consensus estimate of $117.69 million.
For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regency Centers (REG) Tops Q2 EPS by 2c
- Kotak Upgrades Mahanagar Gas Limited (MAHGL:IN) to Reduce (3)
- Home Federal Bancorp of Louisiana (HFBL) Tops Q2 EPS by 46c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
